RT @ATS_BSHSR: Long-acting muscarinic antagonists (LAMA) added to ICS versus higher dose ICS for adults with #asthma. https://t.co/03hmbj3S…

RT @ATS_BSHSR: Long-acting muscarinic antagonists (LAMA) added to ICS versus higher dose ICS for adults with #asthma. https://t.co/03hmbj3S…

RT @ATS_BSHSR: Long-acting muscarinic antagonists (LAMA) added to ICS versus higher dose ICS for adults with #asthma. https://t.co/03hmbj3S…

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults… https://t.co/YB26MFfNS3

@CochraneAirways #Tiotropium in #asthma 2: LAMA added to ICS versus higher dose ICS. http://t.co/5amsNSJimr #RespEd

RT @UKCPAResp: Cochrane RV #LAMA vs double dose #ICS for #asthma :Insufficient data to assess diff in efficacy/safety for Step 3 tx http://…

RT @UKCPAResp: Cochrane RV #LAMA vs double dose #ICS for #asthma :Insufficient data to assess diff in efficacy/safety for Step 3 tx http://…

RT @UKCPAResp: Cochrane RV #LAMA vs double dose #ICS for #asthma :Insufficient data to assess diff in efficacy/safety for Step 3 tx http://…

Cochrane RV #LAMA vs double dose #ICS for #asthma :Insufficient data to assess diff in efficacy/safety for Step 3 tx http://t.co/dOHkGCUUeB

RT @FarmaciaOesteAP: (Cochrane) LAMA + CI vs. mayores dosis de CI en adultos con asma: evidencia insuficiente http://t.co/PsezMnWeO7

(Cochrane) LAMA + CI vs. mayores dosis de CI en adultos con asma: evidencia insuficiente http://t.co/PsezMnWeO7

Cochrane: Nada claras las ventajas de añadir LAMA a corticoide inhalado (vs inc. dosis corticoide) en asma adultos http://t.co/Yw6STO6RPD

Conclusion: need more studies MT @Asthma3Ways LAMA+inhaled steroids for asthma (Cochrane) http://t.co/NyluwUpgqb http://t.co/yfQCaBds2K

Conclusion: need more studies MT @Asthma3Ways LAMA+inhaled steroids for asthma (Cochrane) http://t.co/NyluwUpgqb http://t.co/yfQCaBds2K

Conclusion: need more studies MT @Asthma3Ways LAMA+inhaled steroids for asthma (Cochrane) http://t.co/NyluwUpgqb http://t.co/yfQCaBds2K

Long-acting muscarinic antagonists added to inhaled steroids vs higher dose ICS for adults w/ asthma http://t.co/mtxzeyOyIv

Long-acting muscarinic antagonists added to inhaled steroids vs higher dose ICS for adults w/ asthma http://t.co/5X0sUb6GdP

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults… http://t.co/DPUBb6gNQc

New #CochraneEvidence on effects of adding a LAMA to any dose of ICS vs increasing ICS dose for uncontrolled #asthma: http://t.co/lqnGteSRJ5

New #CochraneEvidence on effects of adding a LAMA to any dose of ICS vs increasing ICS dose for uncontrolled #asthma: http://t.co/lqnGteSRJ5

New #CochraneEvidence on effects of adding a LAMA to any dose of ICS vs increasing ICS dose for uncontrolled #asthma: http://t.co/lqnGteSRJ5

New #CochraneEvidence on effects of adding a LAMA to any dose of ICS vs increasing ICS dose for uncontrolled #asthma: http://t.co/lqnGteSRJ5

New #CochraneEvidence on effects of adding a LAMA to any dose of ICS vs increasing ICS dose for uncontrolled #asthma: http://t.co/lqnGteSRJ5

New #Cochrane review: Long-acting muscarinic antagonists (LAMA) added to ICS vs higher dose ICS for adults w/asthma http://t.co/EjLBRPmjbV

SAEs &hospitalisations occurred in similarly low numbers of pts on each treatment; CIs too wide to prove equivalence http://t.co/RLvhgiHpTa

Review included 1 crossover RCT on 210 people w/mod-severe asthma. Compared tiotropium w/double dose beclomethasone http://t.co/NBsQMqFrCm

New #Cochrane review: Long-acting muscarinic antagonists (LAMA) added to ICS vs higher dose ICS for adults w/asthma http://t.co/EjLBRPmjbV

Adding up: @CochraneAirways review finds that tiotropium reduces #asthma attacks when combined with inhaled steroids http://t.co/qeBVrjJXjk